Cellectis S.A. Share Price
NASDAQ: CLLSCellectis S.A. Stock Performance
Cellectis S.A. Share Price Today
As of 30 October 2026, Cellectis S.A.'s share price is $1.15. The stock opened at $1.22, compared to its previous close of $1.24. During today's trading session, Cellectis S.A.'s share price traded between $1.16 and $1.22, with an average price of $1.19. Over the past 52 weeks, the stock has recorded a high of $5.33 and a low of $0.90. In terms of performance, Cellectis S.A.'s share price has declined by 69.25% over the last six months and is down 66.76% on a year-on-year basis.
Cellectis S.A. Share Price Chart
About Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
Cellectis S.A. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.46 | $1.17 | -22.00% |
Sep 2026 | $3.20 | $1.50 | -55.49% |
Aug 2026 | $2.74 | $3.37 | +20.79% |
Jul 2026 | $3.00 | $2.79 | -7.31% |
Jun 2026 | $3.60 | $3.01 | -15.45% |
May 2026 | $3.73 | $3.56 | -4.81% |
Apr 2026 | $3.40 | $3.74 | +19.87% |
Mar 2026 | $3.92 | $3.12 | -19.79% |
Feb 2026 | $3.87 | $3.89 | +0.26% |
Jan 2026 | $4.87 | $3.88 | -19.67% |
Dec 2025 | $4.72 | $4.83 | -4.17% |
Nov 2025 | $3.25 | $5.04 | +45.66% |